PT-141
Research Compound PT-141 Bremelanotide (CAS 189691-06-3)
A cyclic heptapeptide melanocortin receptor agonist derived from alpha-melanocyte-stimulating hormone (alpha-MSH). Studied for its binding affinity at MC3R and MC4R subtypes, hypothalamic signaling modulation, and dopaminergic pathway interaction in preclinical laboratory models.
ESI-MS identity confirmed · Batch-specific COA included
Compound Specifications
189691-06-3
1025.19 g/mol
Lyophilized Powder
-20°C
Available Sizes
For laboratory research use only. Not for human or animal consumption. Must be 21+. This product is not intended to diagnose, treat, cure, or prevent any disease. Nothing on this site constitutes medical advice.
HPLC Verified
Reverse-phase HPLC purity analysis on every production batch. Raw chromatogram data included on COA.
ESI-MS Confirmed
Electrospray ionization mass spectrometry confirms molecular weight and sequence identity for every lot.
Batch-Specific COA
Each order ships with a certificate of analysis tied to its unique lot number — not a generic document.
More in Wellness
Wellness
NAD+
99.0% purity
An essential coenzyme in cellular redox reactions and NAD+/NADH cycling. Studied for its role in sirtuin activation, PARP pathway modulation, and mitochondrial bioenergetics in preclinical laboratory models.